marginally significantp=0.08
Analysis by subcategories of damage in the whole cohort A significant global reduction in the risk for accruing lupus-related damage was seen among MP users (adjusted HR 0.28, 95% CI 0.09 to 0.82, p=0.02), with a marginally significant risk reduction of GC-related damage (adjusted HR 0.37, 95% CI 0.12 to 1.13, p=0.08).